Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
Revenue Breakdown
Breakdown by Geography
Regeneron Pharmaceuticals Inc
Breakdown by Segments
Regeneron Pharmaceuticals Inc
|
Total Revenue:
14.3B
USD
|
|
Net Product Sales:
7.6B
USD
|
|
Collaboration Revenue:
6.1B
USD
|
|
Libtayo:
1.2B
USD
|
|
Reimbursement Of Commercialization-Related Ex...:
655.4m
USD
|
|
Other Revenue:
515m
USD
|
|
Reimbursement For Manufacturing Of Commercial...:
95.7m
USD
|
|
Regeneron's Share Of Profits:
1.4m
USD
|